METHODS: We retrospectively enrolled 109 patients. The CONUT score was based on serum albumin level, lymphocyte count, and total cholesterol level. Receiver-operating characteristic curve analysis for relapse-free survival (RFS) was performed, and the maximum Youden index was used to set the cutoff value of CONUT score. According to this cutoff, patients were classified into two groups (i.e., high and low CONUT score). RFS, cancer-specific survival (CSS), and overall survival (OS) after RNU were compared, and predictors of survival were analyzed.
INTRODUCTION AND OBJECTIVES: Radical nephroureterectomy (RNU) is the gold standard for management of bulky, invasive, or high grade upper-tract urothelial carcinoma (UTUC). Patients undergoing RNU are elderly and comorbid therefore placing them at risk for complications following surgery. We review an international multicenter cohort of RNU patients to identify the incidence of major complications and risk factors for their occurrence.
METHODS: The charts of 1266 patients undergoing RNU at 14 international academic medical centers between 2002 and 2015 were reviewed. Preoperative clinical, demographic, and comorbidity indices were collected. Complications occurring within 30 days of surgery were graded using the modified Clavien-Dindo scale. Multivariate logistic regression determined the association between preoperative variables and Clavien III or greater post-RNU complications.
RESULTS: A total of 707 men and 559 women with a median age of 70 years and body mass index of 27 kg/m2 were included. Almost 80% of the cohort was white, 17% had an Eastern Cooperative Oncology Group (ECOG) performance status 2, 22% had a Charlson comorbidity index (CCI) score > 5 and 50% had baseline chronic disease (CKD) stage III. Overall, 413 (33%) experienced a complication including 103 (8.1%) with a Clavien grade III. Specific distribution of major complications included 49 Clavien III, 44 Clavien IV, and 10 Clavien V. On univariate analysis, patient age (p¼0.006), ASA score (p¼0.02), ECOG (p<0.0001), CCI (p<0.0001), HTN (p¼0.002), DM (p¼0.02), and CKD stage (p<0.001) all were associated with major complications. A multivariate linear regression model highlighted that ECOG 2 (OR 2.38, p¼0.001), CCI > 5 (OR 3.44, p¼0.007), and CKD stage 3 (OR 3.64, p¼0.008) were independently associated with major complications. (Table) CONCLUSIONS: Major complications occur in 8% of patients undergoing RNU. Impaired preoperative performance status (as determined by ECOG or Charlson comorbidity index) and baseline CKD are associated with a major post-surgical adverse event. These easily measurable indices warrant consideration prior to proceeding with RNU.
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MP78-14 IMPORTANCE OF TUMOR SIZE AS RISK STRATIFICATION PARAMETER IN UPPER TRACT UROTHELIAL CARCINOMA (UTUC)
INTRODUCTION AND OBJECTIVES: One of the major challenges regarding upper tract urothelial carcinoma (UTUC) is to identify patients who can safely be managed by kidney-sparing surgery (KSS). European Association of Urology (EAU) Guidelines proposed criteria for pre-treatment risk stratification includes a tumor diameter >1cm as exclusion criteria for KSS. Our aim was to evaluate the performance of different tumor diameters for identifying advanced pathologic stage after RNU and to assess its prognostic value on survival.
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THE JOURNAL OF UROLOGY â Vol. 197, No. 4S, Supplement, Monday, May 15, 2017 METHODS: A multi-institutional retrospective study was conducted that included 800 patients undergoing radical nephroureterectomy (RNU) for non-metastatic UTUC between 1988 and 2016. Tumor sizes were pathologically assessed and categorized into four groups: 1, 1.1-2, 2.1-3, >3 cm. We performed logistic regression analyses to compare different diameter thresholds in predicting advanced pathologic stage. Kaplan-Meier analyses with log rank test for comparison was used for the estimation of survival outcomes. RESULTS: Overall, 31 (3.9%) patients had a tumor size 1cm, 107 (13.4%) 1.1-2cm, 175 (21.9%) 2.1-3cm and 487 (60.9%) >3cm. In preoperative predictive models, that adjusted for the effects of clinicopathologic features, tumor diameters >2cm versus 2cm (OR 1.90, p¼0.011) and >3cm versus 3 (OR 1.71, p¼0.003), were both independently associated with advanced stage (pT2). The addition of tumor size improved the accuracy of the model from 59 to 61 %. Previous bladder cancer (p¼0.011) and preoperative hydronephrosis (p¼0.015) were also associated with pT2 disease. Tumor sizes >2cm or 2cm predicted muscle-invasion (pT2) with 57% positive predictive value (PPV) and 59% negative predictive value (NPV), respectively. With a threshold of 3cm the PPV was 59% and NPV 54%. Kaplan-Meier curves did not show a prognostic impact of tumor size on recurrencefree and cancer-specific survival after RNU.
CONCLUSIONS: Tumor size of 2cm seems to best identify patients who likely harbor muscle-invasive tumor stage. This puts the current risk stratification of EAU Guidelines based on 1cm into question. Our study is limited by the small sample size of 1cm tumors and its design (RNU cohort, retrospective, multi-institutional). Therefore, this area needs further research to better identify the optimal criteria for KSS.
Source of Funding: none
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ROBOTIC RADICAL NEPHROURETERECTOMY IS ASSOCIATED WITH POORER ONCOLOGICAL OUTCOMES THAN OPEN AND LAPAROSCOPIC RADICAL NEPHROURETERECTOMY benoit peyronnet*, rennes, France; nicolas brichart, orl eans, France; franck bruyere, tours, France; quentin alimi, tondut lauranne, romain mathieu, rennes, France; christophe vaessen, thomas seisen, paris, France; benjamin pradere, rennes, France; adham rammal, orleans, France; victor vanalderwerelt, tours, France; gregory verhoest, rennes, France; pierre colin, lille, France; morgan roupret, paris, France; karim bensalah, rennes, France INTRODUCTION AND OBJECTIVES: In recent years several teams have reported their techniques of robot-assisted radical nephroureterectomy (RARNU) whose main benefit is to facilitate the laparoscopic resection of the bladder cuff, which was usually performed through a Gibson incision in case of laparoscopic radical nephroureterectomy (LRNU). The objective of this study was to compare the oncological outcomes and and patterns of recurrence after RARNU vs. open RNU (ORNU) vs. LRNU.
METHODS: All patients who underwent a RNU in four centers between 2008 and 2016 were included in a retrospective study. The patients were divided into three groups: RARNU, ORNU, and LRNU. The recurrence-free survival (RFS), cancer-specific (CSS), overall survival (OS) and bladder-recurrence-free survival (BRFS) were estimated using the Kaplan-Meier method and compared using the log-rank test. The prognostic factors associated with RFS, BRFS, OS and CSS were assessed using a multivariate Cox regression model. The chi2 test was used to compare recurrence sites between the three groups.
RESULTS: In total, 185 patients were included : 50 in the ORNU group, 93 in the LRNU group and 42 in the RARNU group. After a median follow up of 22 months, there were 34 recurrences (18.4%) with similar rates of peritoneal carcinomatosis in the three groups (15.8% vs. 12.5% vs. 14.3%; p¼0.98 ). OS and CSS were similar in the three groups. However RFS was poorer in the robotic group compared to the open and laparoscopic groups (1 year: 57.7% vs. 76.1% vs. 76.7%; p ¼ 0.02) as well as BRFS (1 year: 57.1% vs. 81.6% vs. 74.8%; p ¼ 0.04). In multivariate analysis, the robotic approach was associated with BRFS (OR ¼ 8.7; p ¼ 0.01) but not with RFS (OR ¼ 1.7; p ¼ 0.92).
CONCLUSIONS: In this multicenter study, robot-assisted radical nephroureterectomy was associated with poorer RFS and BRFS than laparoscopic and open radical nephroureterectomy. In multivariate analysis, the robotic approach was associated with poorer BRFS but not RFS. Further studies with long-term follow-up are needed to confirm these findings.
